BRAF and colorectal carcinoma: Patients with primary chemotherapy: Four out of nine patients who received primary chemotherapy (LB-CRC-02, LB-CRC-30, LB-CRC-32, LB-CRC-43) were diagnosed with stage IV CRC (two out of four BRAF and two out of four KRAS variants).